MCL1 and hemorrhage: Furthermore, MCL-1 gene silencing disabled both the cytoprotective activity of VPA treatment and its ability to facilitate mitochondrial ATP production; however, MCL-1 overexpression facilitated both cytoprotective activity and ATP production, suggesting a key role of MCL-1 in the pharmacological effect of VPA and the pathogenesis of hemorrhage-induced organ dysfunction.